New invasive mosquito pilot program launching in July
(FOX40.COM) — The Sacramento-Yolo Mosquito and Vector Control District is launching a new invasive mosquito control program next month in South Natomas.
The sterile male mosquito pilot program aims to combat the spread of Aedes Aegypti mosquitoes, reduce mosquito populations, and protect residents' health. The program starts in July and runs through October.
Investigation underway after dead body found wrapped in blanket in Sacramento
'Invasive mosquitoes have been spreading rapidly within our area,' said Luz Maria Robles, Public Information Officer for the Sacramento-Yolo Mosquito and Vector Control District. 'Over the last few years, we've definitely been picking more and more of them up in our traps. So we've been finding more adults as well as more immature mosquitoes in those small sources where they breed.'
The spread of the Aedes Aegypti mosquito, which was initially brought to California in a shipment of bamboo plants, is surging in Northern California. Allowing them to breed, stagnant pools of water. Flower pots, bird baths, and outdoor dog bowls, for example, can become breeding grounds for these pests.
How does ICE know who to deport?
'A container as small as a bottle cap of water would be enough to breed these mosquitoes,' said Robles.
As populations of Aedes Aegypti mosquitoes grow, so does the chance of contracting dangerous and even deadly diseases.
Deputies seize nearly 7,000 marijuana plants in Northern California drug bust
'They pose a health threat for dengue, zika, and chikungunya,' Robles said. 'Now that we have these mosquitoes very well established in our area, we could see locally acquired cases of dengue.'
That's why the Sacramento-Yolo Mosquito and Vector Control District is launching this program. Robles said mosquito control staff will release sterile male mosquitoes twice a week in South Natomas once the program begins.
'We'll be releasing sterile males that have a bacteria called Wolbachia,' she said. 'When they mate with the wild females in the area, then their eggs won't hatch. So it's a way of reducing mosquito populations over time.'
These sterile male mosquitoes don't bite either, easing concerns for South Natomas residents already experiencing swarms of mosquitoes.
'You have to put up, like, you know, like shades, or you have to put up a curtain, you know what I mean? Like, so the mosquitoes don't get around or irritate you. It's a problem,' said area resident Jalen Garrison.
'Now I feel more safer with them combating, you know, what was just a nuisance like 3 or 4 years ago,' said Garrison.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
33 minutes ago
- CBS News
Chevron Richmond refinery, Air District reach agreement on hazardous gas monitoring
The Bay Area Air District (BAAD) reached an agreement with Chevron on a new air pollution monitoring system at its Richmond refinery that will bring enhanced monitoring for hydrogen sulfide, a smelly and potentially dangerous gas previously not properly monitored according to the Air District's standards. Chevron is the first of the five oil refineries in the nine-county BAAD to reach an agreement with the Air District after all the refineries' fenceline monitoring programs were deemed insufficient and were "disapproved" in October 2023. The agreement announced by the Air District Tuesday will implement a new, more robust monitoring system for hydrogen sulfide, increased data sharing, and more community outreach from the company. Chevron also agreed to pay a penalty of $100,000 to the Air District and agreed to pay further penalties if it violates the settlement agreement, according to the Air District. Hydrogen sulfide, or H2S, is a colorless, hazardous gas that is heavier than air and is a biproduct of the refining process. It can smell like rotten eggs in low concentrations and is also referred to as sewer gas, swamp gas, stink damp, and sour damp, according to the U.S. Occupational Health and Safety Administration (OSHA). Health effects can occur even at low levels and include tearing eyes, headaches, nausea and vomiting. Exposure to sulfur dioxide can cause loss of consciousness or death, according to OSHA. The Air District previously required refineries in the Bay Area to monitor the gas with an "open line" monitoring system, which uses a beam of light to measure the presence of hydrogen sulfide over a large area. But in 2022 it told Chevron and others that their fenceline monitoring plans, which detect pollutants at the properties' edge, or fenceline, were deficient and needed to be remade. When the companies submitted their new plans the following year, they were each deemed out of regulatory compliance. Chevron's deficiencies, and necessary corrections, centered around the number of data points that would be created by the monitoring technology, which are supposed to hit a certain threshold both hourly and quarterly. Other issues revolved around how the data was formatted and transmitted to regulators and retained for public review. Under the settlement agreement, Chevron will install a network of four "point monitors" which will have a lower detection threshold for hydrogen sulfide. They detect the gas at certain points rather than over large areas and are said to be more accurate than the open line system currently being used. They are also more reliable in bad weather conditions, such as dense fog, that hampered the open line monitors, according to the BAAD. "This settlement goes beyond what's required, and it reflects the Air District's commitment to transparency, enforcement and public health," said the Air District's executive officer, Philip Fine. "It raises the bar for transparency and community access to air quality data, setting a positive example for the industry." The website maintained by Chevron to report air quality data to the public, will now maintain data for five years, rather than the current three months, and make the data downloadable. A spokesperson for Chevron said the agreement would essentially enhance the monitoring the company was already doing at the refinery. "We know data and transparency are important to our community and are proud to be the first refinery in the Bay Area to move forward with these improvements," the company said in a statement. Chevron will also hold a community meeting to discuss its monitoring program sometime before the end of the year, but it was not yet scheduled as of Wednesday.


Fox News
an hour ago
- Fox News
RFK Jr. picks eight for vaccine panel after firing all 17 members
Health and Human Services Secretary Robert F. Kennedy Jr. announced Wednesday that he has selected eight new people to join the national vaccine panel after firing all 17 of its members. In an X post, Kennedy revealed that he "took a major step towards restoring public trust in vaccines" on Monday by reconstituting the Advisory Committee for Immunization Practices (ACIP). "I retired the 17 current members of the committee. I'm now repopulating ACIP with the eight new members who will attend ACIP's scheduled June 25 meeting," Kennedy wrote on Wednesday. "The slate includes highly credentialed scientists, leading public-health experts, and some of America's most accomplished physicians. All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense." The new members are: Joseph R. Hibbeln, MD; Martin Kulldorff, MD, PhD; Retsef Levi, PhD; Robert W. Malone, MD; Cody Meissner, MD; James Pagano, MD; Vicky Pebsworth, OP, PhD, RN; and Michael A. Ross, MD. The secretary said all eight people "have each committed to demanding definitive safety and efficacy data before making any new vaccine recommendations." He said the committee will review safety and efficacy data for the current schedule." Notably, Kulldorff was one of the co-authors of the Great Barrington Declaration, which was written alongside Dr. Sunetra Gupta of Oxford University and Dr. Jay Bhattacharya of Stanford University. The declaration, published in October 2020, promoted lifting lockdown orders sooner and allowing COVID-19 to spread among young, healthy people to more quickly reach herd immunity. The strategy also included precautions to shield those most vulnerable to severe illness, and the authors said the approach would help mitigate the long-term societal and economic harms of prolonged lockdown orders. It was condemned harshly at the time by the World Health Organization and Dr. Anthony Fauci, then-Director of the U.S. National Institute of Allergy and Infectious Diseases. On Tuesday, before he announced his picks, Kennedy said, "We're going to bring great people onto the ACIP panel – not anti-vaxxers – bringing people on who are credentialed scientists." Kennedy on Monday ousted all 17 members of the ACIP, saying he would appoint a new group before the next scheduled meeting in late June. The agenda for that meeting has not yet been posted, but a recent federal notice said votes are expected on vaccinations against flu, COVID-19, HPV, RSV and meningococcal bacteria. ACIP members typically serve staggered four-year terms, although several appointments were delayed during the Biden administration before positions were filled last year. The voting members all have scientific or clinical expertise in immunization, except for one "consumer representative" who can bring perspective on community and social facets of vaccine programs. The committee, created in 1964, makes recommendations to the director of the Centers for Disease Control and Prevention. Kennedy provided a brief biography of each of his new picks. Hibbeln is a psychiatrist and neuroscientist with a career in clinical research, public health policy and federal service. "As former Acting Chief of the Section on Nutritional Neurosciences at the National Institutes of Health, he led research on immune regulation, neurodevelopment, and mental health," Kennedy wrote. "His work has informed U.S. public health guidelines, particularly in maternal and child health. With more than 120 peer-reviewed publications and extensive experience in federal advisory roles, Dr. Hibbeln brings expertise in immune-related outcomes, psychiatric conditions, and evidence-based public health strategies." Kulldorff is a biostatistician and epidemiologist formerly at Harvard Medical School and a leading expert in vaccine safety and infectious disease surveillance. "He has served on the Food and Drug Administration's Drug Safety and Risk Management Advisory Committee and the CDC's Vaccine Safety Subgroup of the Advisory Committee on Immunization Practices, where he contributed to national vaccine safety monitoring systems," Kennedy wrote, adding that he developed tools used "for detecting disease outbreaks and vaccine adverse events.," and has expertise that "includes statistical methods for public health surveillance, immunization safety, and infectious disease epidemiology." Levi is the Professor of Operations Management at the MIT Sloan School of Management and a leading expert in healthcare analytics, risk management, and vaccine safety. "Dr. Levi has collaborated with public health agencies to evaluate vaccine safety, including co-authoring studies on mRNA COVID-19 vaccines and their association with cardiovascular risks. His research has contributed to discussions on vaccine manufacturing processes, safety surveillance, and public health policy," Kennedy wrote, adding that Levi "has also served on advisory committees and engaged in policy discussions concerning vaccine safety and efficacy," and that his "work continues to inform national and international debates on immunization safety and health system resilience." Malone is a physician-scientist and biochemist known for his early contributions to mRNA vaccine technology, specifically "foundational research in the late 1980s on lipid-mediated mRNA delivery, which laid the groundwork for later developments in mRNA-based therapeutics," Kennedy wrote, adding that Malone's "expertise spans molecular biology, immunology, and vaccine development." Meissner is a Professor of Pediatrics at the Geisel School of Medicine at Dartmouth and a nationally recognized expert in pediatric infectious diseases and vaccine policy. "He has served as Section Chief of Pediatric Infectious Disease at Dartmouth-Hitchcock Medical Center and has held advisory roles with both the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA)," Kennedy wrote, adding that Meissner was a voting member of the CDC's Advisory Committee on Immunization Practices and the FDA's Vaccines and Related Biological Products Advisory Committee, through which "he has contributed to national immunization guidelines and regulatory decisions." "His expertise spans vaccine development, immunization safety, and pediatric infectious disease epidemiology. Dr. Meissner has also been a contributing author to American Academy of Pediatrics policy statements and immunization schedules, helping shape national standards for pediatric care." Pagano is a board-certified Emergency Medicine physician with over 40 years of clinical experience following his residency at UCLA. "He has worked in diverse emergency settings, from Level 1 trauma centers to small community hospitals, caring for patients across all age groups, including infants, pregnant women, and the elderly," Kennedy wrote, adding that he has also served on various committees and medical executive boards. "He is [a] strong advocate for evidence-based medicine." Pebsworth earned a doctorate in public health and nursing from the University of Michigan. "She has worked in the healthcare field for more than 45 years, serving in various capacities, including critical care nurse, healthcare administrator, health policy analyst, and research scientist with a focus on public health policy, bioethics, and vaccine safety," Kennedy wrote, pointing to her current leadership role with the National Association of Catholic Nurses, and previous positions with the FDA's Vaccine and Related Biological Products Advisory Committee, the National Vaccine Advisory Committee's 2009 H1N1 Vaccine Safety Risk Assessment Working Group and Vaccine Safety Working Group. Ross is a Clinical Professor of Obstetrics and Gynecology at George Washington University and Virginia Commonwealth University, with a career spanning clinical medicine, research, and public health policy. "He has served on the CDC's Advisory Committee for the Prevention of Breast and Cervical Cancer, where he contributed to national strategies for cancer prevention and early detection, including those involving HPV immunization," Kennedy wrote, pointing to his experience with "clinical investigations with immunologic relevance," advising organizations like the American College of Obstetricians and Gynecologists, and advocacy efforts related to women's health. "His continued service on biotech and healthcare boards reflects his commitment to advancing innovation in immunology, reproductive medicine, and public health," Kennedy added.


Bloomberg
2 hours ago
- Bloomberg
RFK Jr.'s Moves Leave Insurance Coverage of Vaccines in Doubt
Public health experts are taking it upon themselves to counter recent moves by Health and Human Services Secretary Robert F. Kennedy Jr. that could dramatically change US vaccine policy. They have formed a shadow group of specialists who can give recommendations on who should receive which vaccines, and are urging insurers to continue paying for shots.